Genetesis

Genetesis is a commercial-stage medical technology company redefining the way myocardial ischemia and coronary artery disease are clinically diagnosed and triaged by combining our noninvasive biomagnetic imaging technology with proprietary cloud-based web services and machine-learning capabilities. Our initial goal is to be the ultimate rule-out test, in combination with the 12-lead EKG and serial troponins, for clinically significant myocardial ischemia in the acute care setting, We have created a unique web microservices architecture, called the Faraday Analytical Cloud, which combines our easy-to-operate and highly available noninvasive biomagnetic imaging device, called the CardioFlux FAC Magnetocardiograph, with powerful proprietary algorithms that distill data from the device’s measured magnetic field maps into clinically actionable information that integrates seamlessly into clinical and revenue cycle management workflows.